S100A4 and breast cancer: Some of the proteins that were modulated in the present study such as S100A4 or haptoglobin were also described in previous studies on canine mammary tumors [27] or human breast cancer [14,15,28,29], while other proteins including immunoglobulin gamma-heavy chains A and D or kallikrein-1 were described here for the first time as CMT-related proteins.